NUVEEN CA QLTY MUNI INC (NAC) Fundamental Analysis & Valuation

NYSE:NAC • US67066Y1055

Current stock price

11.95 USD
+0.04 (+0.34%)
Last:

This NAC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NAC Profitability Analysis

1.1 Basic Checks

  • In the past year NAC was profitable.
  • NAC had a positive operating cash flow in the past year.
  • In multiple years NAC reported negative net income over the last 5 years.
  • Each year in the past 5 years NAC had a positive operating cash flow.
NAC Yearly Net Income VS EBIT VS OCF VS FCFNAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 1.52%
ROE 2.57%
ROIC 1.71%
ROA(3y)-2.2%
ROA(5y)0.41%
ROE(3y)-3.7%
ROE(5y)0.46%
ROIC(3y)N/A
ROIC(5y)N/A
NAC Yearly ROA, ROE, ROICNAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • NAC's Profit Margin has improved in the last couple of years.
  • NAC's Operating Margin has declined in the last couple of years.
  • In the last couple of years the Gross Margin of NAC has declined.
Industry RankSector Rank
OM 48.18%
PM (TTM) 34.01%
GM 48.89%
OM growth 3Y-13.04%
OM growth 5Y-6.45%
PM growth 3YN/A
PM growth 5Y14.26%
GM growth 3Y-13.4%
GM growth 5Y-6.64%
NAC Yearly Profit, Operating, Gross MarginsNAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NAC Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, NAC has more shares outstanding
  • Compared to 5 years ago, NAC has more shares outstanding
  • NAC has a better debt/assets ratio than last year.
NAC Yearly Shares OutstandingNAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
NAC Yearly Total Debt VS Total AssetsNAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • NAC has an Altman-Z score of 0.95. This is a bad value and indicates that NAC is not financially healthy and even has some risk of bankruptcy.
  • NAC has a debt to FCF ratio of 18.28. This is a negative value and a sign of low solvency as NAC would need 18.28 years to pay back of all of its debts.
  • A Debt/Equity ratio of 0.69 indicates that NAC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 18.28
Altman-Z 0.95
ROIC/WACCN/A
WACCN/A
NAC Yearly LT Debt VS Equity VS FCFNAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • NAC has a Current Ratio of 2.79. This indicates that NAC is financially healthy and has no problem in meeting its short term obligations.
  • NAC has a Quick Ratio of 2.79. This indicates that NAC is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 2.79
NAC Yearly Current Assets VS Current LiabilitesNAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NAC Growth Analysis

3.1 Past

  • The earnings per share for NAC have decreased strongly by -58.44% in the last year.
  • NAC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.84% yearly.
  • NAC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.46%.
  • Measured over the past years, NAC shows a decrease in Revenue. The Revenue has been decreasing by -2.23% on average per year.
EPS 1Y (TTM)-58.44%
EPS 3YN/A
EPS 5Y11.84%
EPS Q2Q%-97.37%
Revenue 1Y (TTM)4.46%
Revenue growth 3Y0.45%
Revenue growth 5Y-2.23%
Sales Q2Q%0%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAC Yearly Revenue VS EstimatesNAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NAC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 37.34 indicates a quite expensive valuation of NAC.
  • NAC is valuated rather expensively when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.34
Fwd PE N/A
NAC Price Earnings VS Forward Price EarningsNAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 27.69
EV/EBITDA N/A
NAC Per share dataNAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.15
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NAC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.77%, NAC is a good candidate for dividend investing.
  • NAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.77%

5.2 History

  • NAC has paid a dividend for at least 10 years, which is a reliable track record.
  • NAC has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NAC Yearly Dividends per shareNAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 143.76% of the earnings are spent on dividend by NAC. This is not a sustainable payout ratio.
DP143.76%
EPS Next 2YN/A
EPS Next 3YN/A
NAC Yearly Income VS Free CF VS DividendNAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
NAC Dividend Payout.NAC Dividend Payout, showing the Payout Ratio.NAC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NAC Fundamentals: All Metrics, Ratios and Statistics

NUVEEN CA QLTY MUNI INC

NYSE:NAC (5/1/2026, 8:04:00 PM)

11.95

+0.04 (+0.34%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)05-02
Earnings (Next)N/A
Inst Owners14.43%
Inst Owner Change-0.95%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.85B
Revenue(TTM)135.00M
Net Income(TTM)45.91M
Analysts45
Price TargetN/A
Short Float %0.24%
Short Ratio0.62
Dividend
Industry RankSector Rank
Dividend Yield 6.77%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP143.76%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 37.34
Fwd PE N/A
P/S 13.74
P/FCF 27.69
P/OCF 27.69
P/B 1.04
P/tB 1.04
EV/EBITDA N/A
EPS(TTM)0.32
EY2.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.43
FCFY3.61%
OCF(TTM)0.43
OCFY3.61%
SpS0.87
BVpS11.5
TBVpS11.5
PEG (NY)N/A
PEG (5Y)3.15
Graham Number9.09908 (-23.86%)
Profitability
Industry RankSector Rank
ROA 1.52%
ROE 2.57%
ROCE 2.16%
ROIC 1.71%
ROICexc 1.71%
ROICexgc 1.71%
OM 48.18%
PM (TTM) 34.01%
GM 48.89%
FCFM 49.63%
ROA(3y)-2.2%
ROA(5y)0.41%
ROE(3y)-3.7%
ROE(5y)0.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-8.11%
ROICexgc growth 5Y-6.36%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-6.36%
OM growth 3Y-13.04%
OM growth 5Y-6.45%
PM growth 3YN/A
PM growth 5Y14.26%
GM growth 3Y-13.4%
GM growth 5Y-6.64%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 18.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.3
Cash Conversion N/A
Profit Quality 145.94%
Current Ratio 2.79
Quick Ratio 2.79
Altman-Z 0.95
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.44%
EPS 3YN/A
EPS 5Y11.84%
EPS Q2Q%-97.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.46%
Revenue growth 3Y0.45%
Revenue growth 5Y-2.23%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.16%
EBIT growth 3Y-12.65%
EBIT growth 5Y-8.54%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.68%
FCF growth 3Y-16.33%
FCF growth 5Y-9.67%
OCF growth 1Y-52.68%
OCF growth 3Y-16.33%
OCF growth 5Y-9.67%

NUVEEN CA QLTY MUNI INC / NAC Fundamental Analysis FAQ

What is the fundamental rating for NAC stock?

ChartMill assigns a fundamental rating of 2 / 10 to NAC.


What is the valuation status of NUVEEN CA QLTY MUNI INC (NAC) stock?

ChartMill assigns a valuation rating of 0 / 10 to NUVEEN CA QLTY MUNI INC (NAC). This can be considered as Overvalued.


What is the profitability of NAC stock?

NUVEEN CA QLTY MUNI INC (NAC) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for NAC stock?

The Price/Earnings (PE) ratio for NUVEEN CA QLTY MUNI INC (NAC) is 37.34 and the Price/Book (PB) ratio is 1.04.


How financially healthy is NUVEEN CA QLTY MUNI INC?

The financial health rating of NUVEEN CA QLTY MUNI INC (NAC) is 3 / 10.